Swab & Viral Transport Medium Market Size to Hit US$ 2.24 Billion by 2031 | Growth Plus Reports

Swab & Viral Transport Medium Market Size to Hit US$ 2.24 Billion by 2031 | Growth Plus Reports

GlobeNewswire

Published

Newark, New Castle, USA, May 17, 2023 (GLOBE NEWSWIRE) -- Growth Plus Reports studied and calculated the size of the global market for *swab & viral transport medium* in 2022 to be worth *US$ 1.69 billion*, and it is expected to grow at a revenue *CAGR of 3.2%* to reach *US$ 2.24 billion by 2031*.

Analysis of the global market for swab & viral transport mediums indicates that during the forecast period, revenue share is likely to increase significantly. An instrument used in medicine called a swab is used to gather biological samples, such as cells or secretions. Swabs are frequently used to obtain samples from mucous membranes such as the throat, nasal cavity, or other mucous membranes to detect infectious disorders or conduct genetic testing.

*Request a Free Sample PDF: **https://www.growthplusreports.com/inquiry/request-sample/swab-viral-transport-medium-market/8870*

*                          Swab & Viral Transport Medium Market Scope*

*Report Attribute* *Details*
Market Size Value in 2022 US$ 1.69 billion
Revenue Forecast in 2031 US$ 2.24 billion
CAGR 3.2%
Base Year for Estimation 2022
Forecast Period 2023 to 2031
Historical Year 2021
Segments Covered Indication, End user, and Region
Regional Scope North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

*Key Takeaways: *

• The growing incidence and awareness of infectious diseases are driving the market revenue share.

• The swab test's high sensitivity and specificity drive the transport medium market demand.

• The transport and long-term freezing of clinical specimens with viruses are rapidly increasing market revenue growth.

*Recent Development in the Swab & Viral Transport Medium Market: *

· In February 2022, an indigenous biological transport and storage medium was introduced by Azooka Labs for use in research. This is an essential tool for moving and maintaining samples in the pandemic-fighting effort. 
· In June 2022, Safeguard DNA Diagnostics, Inc. started collecting COVID samples utilizing the rhinos-tics, dry nasal, and nasopharyngeal collecting swabs.

*Request for Customization – **https://www.growthplusreports.com/inquiry/customization/swab-viral-transport-medium-market/8870*

*Competitive Landscape*

A list of the key players operating in the global market for swab & viral transport mediums includes: 

· COPAN Diagnostics, Inc.
· Titan Biotech Limited
· Medical Wire & Equipment
· *Thermo Fisher Scientific*
· *Puritan Medical Products*
· *BD & Company *

*Market Drivers and Restraints: *

The global swab & viral transport medium market revenue is driven by the increase in precise disease identification by microbiological techniques, the increase in viral diagnostics, and the reliable results required for personalized treatments. 

However, due to the time taking procedures and presence of alternative transport mediums, the swab & viral transport medium market revenue growth is expected to be restrained. 

*Market Segmentation: *

· Based on types, the swab & viral transport medium market is segmented into transport medium, swab type, nasopharyngeal swabs, throat swabs, and others.
· Based on indications, the swab & viral transport medium market is segmented into herpes simplex virus, influenza virus, and others.
· Based on the end user, the swab & viral transport medium market is segmented into hospitals, specialty clinics, diagnostic laboratories, and others.

*Segmentation By Indication*

Based on the indications, the influenza virus segment dominates the global swab & viral transport medium market with the largest revenue share. This large revenue share of this segment is attributed to the rising prevalence of influenza infection and its high mortality and morbidity rate. Furthermore, for precise diagnostics and disease management, these viral and swab transport media are very important, driving the segment's revenue share.

*Regional Growth Dynamics*

Based on the region, North America, with the largest revenue share, dominates the global swab & viral transport medium market. The revenue share of this segment is attributed to the rising prevalence of viral disease, the presence of several competitive players, and rising investments in healthcare diagnostics and research centers. 

*Report Coverage *

Growth Plus Reports conducted extensive research on the world market for swab & viral transport mediums. We looked at the basic market traits, important investment spheres, regional growth analytics, ten years of revenue projections, rival market players, and mergers and acquisitions.

*Table of Content*

1. *INTRODUCTION*

1. Market Ecosystem
2. Timeline Under Consideration

1. Historical Years – 2021
2. Base Year – 2022
3. Forecast Years – 2023 to 2031

3. Currency Used in the Report

2. *RESEARCH METHODOLOGY *

1. Research Approach
2. Data Collection Methodology
3. Data Sources

1. Secondary Sources 
2. Primary Sources 

4. Market Estimation Approach

1. Bottom Up
2. Top Down 

5. Market Forecasting Model
6. Limitations and Assumptions

3. *PREMIUM INSIGHTS*

1. Current Market Trends (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2022)
3. Regulatory Landscape

4. *MARKET DYNAMICS*

1. Drivers
2. Restraints/Challenges
3.  Opportunities

5. *GLOBAL SWAB AND VIRAL TRANSPORT MEDIUM MARKET - ANALYSIS & FORECAST, BY PRODUCT*

1. Transport Medium
2. Swab Type

1. Nasopharyngeal Swabs
2. Throat Swabs
3. Others

6. *GLOBAL SWAB AND VIRAL TRANSPORT MEDIUM MARKET - ANALYSIS & FORECAST, BY INDICATION*

1. Herpes Simplex Virus
2. Influenza Virus
3. Others

7. *GLOBAL SWAB AND VIRAL TRANSPORT MEDIUM MARKET - ANALYSIS & FORECAST, BY END USER*

1. Hospitals
2. Specialty Clinics
3. Diagnostic Laboratories
4. Others

*SWAB AND VIRAL TRANSPORT MEDIUM MARKET TOC*

*Buy this Premium Research Report: **https://www.growthplusreports.com/checkout-8870*

*VALUE PROPOSITIONS RELATED TO THE REPORT*:

· Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
· Comprehensive quantitative and qualitative insights at segment and sub-segment level
· Covid 19 impact trends and perspective
· Granular insights at global/regional/country level
· Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
· Blanket coverage on competitive landscape
· Winning imperatives
· Exhaustive coverage on 'Strategic Developments' registered by leading players of the market.

*CUSTOMIZATION OPTIONS*:

· Distributor Landscape Assessment
· Pricing Intelligence
· Customer Base Assessment
· Investment & Initiatives Analysis
· 'Business Profile' of Key Players

*Schedule a call with our analyst: **https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction*

*Visit our report store at - **https://www.growthplusreports.com/report-store*

*Browse more latest healthcare reports:*

*Vibrating Mesh Nebulizer Market** by Type (Passive Mesh Nebulizer and Piezoelectric Actuation), End User (Hospitals, Clinics, Home Healthcare) – Global Outlook & Forecast 2023-2031*

*Next-Generation Sequencing (NGS) Data Analysis Market** by Product (Services, NGS Commercial Software, Others), Mode (In-house Data Analysis, Outsourced Data Analysis), Read Length (Short Read Sequencing, Long Read Sequencing), End User (Academic Research, Clinical Research) – Global Outlook & Forecast 2023-2031*

*Hypersensitivity Pneumonitis Market** by Type (Sub-acute Hypersensitivity Pneumonitis, Acute Hypersensitivity Pneumonitis), Treatment (Immunosuppressive, Corticosteroids) – Global Outlook & Forecast 2023-2031*

*Endodontic Files Market** by Type (Manual, Rotary), Material (Stainless Steel, Nickel-titanium), End User (Hospitals & OPDs, Dental Clinics, Others) – Global Outlook & Forecast 2023-2031*

*Langerhans Cell Histiocytosis Treatment Market** by Drug Class (Corticosteroids, Nonsteroidal anti-inflammatory drugs), Distribution Channel (Hospital Pharmacies, Online Pharmacies) – Global Outlook & Forecast 2023-2031*

*About Us:*

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

CONTACT: Manan Sethi
Director, Market Insights
Email: sales@growthplusreports.com
256 Chapman Road
STE 105-4, Newark,
New Castle - 19702, USA
Phone no: +1 888 550 5009
Web: https://www.growthplusreports.com/

Full Article